## Abstract Eight novel derivatives of MAG~3~, containing in their structure two instead of three amide functions, have been synthesized and evaluated. The synthesized ligands were labelled with ^99m^Tc by exchange labelling at 100Β°C and/or by a direct labelling method at room temperature. After la
Synthesis, radiolabelling and biological evaluation of terminal oxamide derivatives of mercaptoacetyltriglycine
β Scribed by S.M. Okarvi; P. Torfs; P. Adriaens; A.M. Verbruggen
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 151 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.568
No coin nor oath required. For personal study only.
β¦ Synopsis
99m Tc-MAG 3 is widely used in clinical nuclear medicine as a potential replacement of 131 I-OIH for renal function studies. The terminal carbonylglycine in the MAG 3 backbone is assumed to be essential for maintaining its efficient renal handling characteristics. A number of MAG 3 -derivatives have been prepared and evaluated in which the terminal carbonylglycine sequence is substituted by an oxamide moiety in order to study the effect of the modified carbonylglycine sequence on the renal handling characteristics. These 'oxamide' derivatives have been synthesized starting from mercaptoacetic acid or cysteamine using the common synthetic procedures of peptide chemistry. These thiol-protected MAG 3 -precursors were labelled with 99m Tc by an exchange method using tartrate as a complexing agent. Biodistribution studies in mice showed that some of these agents were cleared rapidly from the blood and efficiently excreted into the urine and displayed comparable renal excretion characteristics to those of 99m Tc-MAG 3 .
π SIMILAR VOLUMES
A number of MAG 3 -derivatives, containing the three-amide functions modified by inverting the sequence -CO-NH-to -NH-CO-in the firstand/or second-amide functions, have been labelled with 99m Tc in order to study the renal characteristics of the resulting MAG 3 -derivatives versus the reference 99m
Bombesin pseudo-peptide analogues containing a hydroxamide function on the C-terminal part of the molecule, e.g. H-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHOBzl 1 and H-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHOH 2 were synthesized. These compounds were tested for their ability to recognize the bombesin recep